Drug Designing: Open Access
Open Access

ISSN: 2169-0138

Volume 4, Issue 2 (2015)

Editorial

Pages: 1 - 1

The Aptamers. Whether the Paradigm Works in Therapeutic Applications?

Elena G Zavyalova

DOI: 10.4172/2169-0138.1000e126

Share this article

Editorial

Pages: 1 - 1

Diazepine Derivative Compounds as Heat Shock Protein 90 Inhibitor in Oncology

Yusuf Tutar

DOI: 10.4172/2169-0138.1000e127

Share this article

Editorial

Pages: 1 - 1

The Success of Solanezumab Should Drive Renewed Efforts to Develop Small Molecule Anti-Amyloid Agents for Alzheimer's disease Therapy.

Anthony R White

DOI: 10.4172/2169-0138.1000e128

Share this article

Research Article

Pages: 1 - 8

Exposure Adjusted Continuous Reassessment Method (EACRM) - an Adaptive Design Incorporating Time to Toxicity Event for Phase I Dose Finding Studies.

Qi X, Munasinghe W, Hosmane B, Chiu Y and

DOI: 10.4172/2169-0138.1000122

Share this article

Research Article

Pages: 1 - 7

An Insight into Antimicrobial Activity Substituted Benzimidazole Derivatives through QSAR Studies.

Mukesh C Sharma

DOI: 10.4172/2169-0138.1000123

Share this article

Top